← Back to Search

Brain Stimulation

iTBS for Cannabis

N/A
Waitlist Available
Led By Tonisha Kearney-Ramos, PhD
Research Sponsored by New York State Psychiatric Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (inpatient day 3), approx. half-way (inpatient day 10), and 2 weeks (inpatient day 18)
Awards & highlights

Study Summary

This trial will study whether transcranial magnetic stimulation (TMS) can be used to decrease attentional bias to cannabis cues and reduce cannabis use in heavy cannabis users.

Eligible Conditions
  • Cannabis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (inpatient day 3), approx. half-way (inpatient day 10), and 2 weeks (inpatient day 18)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (inpatient day 3), approx. half-way (inpatient day 10), and 2 weeks (inpatient day 18) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Cannabis self-administration (laboratory)
Change in Salience Network drug cue reactivity [functional brain data during Cannabis Stroop functional magnetic resonance imaging (fMRI) task]
Secondary outcome measures
Change in Frequency of cannabis use (outpatient)
Change in Quantity of cannabis use (outpatient)
Time to first cannabis use (outpatient)

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: ActiveExperimental Treatment1 Intervention
Group II: ShamPlacebo Group1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
iTBS
2019
Completed Phase 3
~640

Find a Location

Who is running the clinical trial?

New York State Psychiatric InstituteLead Sponsor
475 Previous Clinical Trials
153,867 Total Patients Enrolled
4 Trials studying Cannabis
136 Patients Enrolled for Cannabis
National Institute on Drug Abuse (NIDA)NIH
2,467 Previous Clinical Trials
2,619,083 Total Patients Enrolled
20 Trials studying Cannabis
1,496 Patients Enrolled for Cannabis
Tonisha Kearney-Ramos, PhDPrincipal InvestigatorNew York State Psychiatric Institute

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current capacity for participants to join this clinical trial?

"Affirmative. Clinicaltrials.gov data confirms that this medical trial, which was first put up on June 1st 2022, is currently seeking participants. Approximately 40 patients are required to be enrolled from a single site."

Answered by AI

Is eligibility for participation in this medical trial still open?

"This particular research program is looking for 40 patients with cannabis addiction aged between 18 and 60. To qualify, applicants must possess these characteristics: Male/non-pregnant female, age range within the given parameters, current user of cannabis products, able to complete all study tasks."

Answered by AI

Is enrollment for this research still available?

"Yes, clinicaltrials.gov displays evidence that this trial was initially posted on June 1st 2022 and is presently recruiting 40 individuals at a single site. The study has been recently modified as of August 1st 2022."

Answered by AI

Is this research program open to those 85 years of age or older?

"Within the bounds of this clinical trial, only those aged 18-60 are eligible for participation. Those under 18 years old can look into 16 other trials and individuals over 65 have 53 options to choose from."

Answered by AI

Who else is applying?

What state do they live in?
New York
California
Other
New Jersey
How old are they?
18 - 65
What site did they apply to?
New York State Psychiatric Institute
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

I smoke a bout 30 joints a week and I do want to find alternatives that will help me cut down.
PatientReceived 2+ prior treatments
well i somke weed and i think its kinda cool that doctors would like to run tests on me for weed.
PatientReceived 2+ prior treatments

How responsive is this trial?

Typically responds via
Phone Call
Most responsive sites:
  1. New York State Psychiatric Institute: < 48 hours
Average response time
  • < 2 Days
Recent research and studies
clinicaltrials.govStudy
Transcranial Magnetic Brain Stimulation to Reduce Cannabis Use in Heavy Cannabis Users
Tonisha Kearney-Ramos 2022. "Transcranial Magnetic Brain Stimulation to Reduce Cannabis Use in Heavy Cannabis Users". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05401929.
~25 spots leftby Jul 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top